Clinical Trials
9 trialsNCT05681039 2026-05-05
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT03114462 2026-04-15
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT01473784 2026-02-10
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT01927744 2025-11-26
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06055868 2025-05-28
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
University of California, San Francisco
Recruiting
NCT01846286 2022-05-25
Neuropathic Pain in Head and Neck Cancer
M.D. Anderson Cancer Center
Unknown
NCT00662662 2020-12-30
Sexual Behavior in Head and Neck Cancer Patients
M.D. Anderson Cancer Center
Unknown
NCT02663583 2019-05-23
Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell
M.D. Anderson Cancer Center
Unknown
NCT01181648 2018-06-20
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
Memorial Sloan Kettering Cancer Center
Completed